Pharmsville Co., Ltd.

KOSDAQ:A318010 Stock Report

Market Cap: ₩33.8b

Pharmsville Valuation

Is A318010 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A318010 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A318010 (₩4370) is trading above our estimate of fair value (₩2900.16)

Significantly Below Fair Value: A318010 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A318010?

Key metric: As A318010 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A318010. This is calculated by dividing A318010's market cap by their current earnings.
What is A318010's PE Ratio?
PE Ratio36.6x
Earnings₩921.79m
Market Cap₩33.77b

Price to Earnings Ratio vs Peers

How does A318010's PE Ratio compare to its peers?

The above table shows the PE ratio for A318010 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average10.8x
A270870 Newtree
3.7xn/a₩53.3b
A900120 CXI Healthcare Technology Group
0.7xn/a₩21.9b
23.8xn/a₩28.6b
15xn/a₩49.5b
A318010 Pharmsville
36.6xn/a₩33.8b

Price-To-Earnings vs Peers: A318010 is expensive based on its Price-To-Earnings Ratio (36.6x) compared to the peer average (10.8x).


Price to Earnings Ratio vs Industry

How does A318010's PE Ratio compare vs other companies in the KR Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A900120 CXI Healthcare Technology Group
0.7xn/aUS$15.71m
No more companies available in this PE range
A318010 36.6xIndustry Avg. 16.0xNo. of Companies4PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A318010 is expensive based on its Price-To-Earnings Ratio (36.6x) compared to the KR Personal Products industry average (15.9x).


Price to Earnings Ratio vs Fair Ratio

What is A318010's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A318010 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio36.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate A318010's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies